Cargando…

Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR

Pharmacologic reversal of serious or intolerable side effects (SISE) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to l...

Descripción completa

Detalles Bibliográficos
Autores principales: Abidov, Aiden, Dilsizian, Vasken, Doukky, Rami, Duvall, W. Lane, Dyke, Christopher, Elliott, Michael D., Hage, Fadi G., Henzlova, Milena J., Johnson, Nils P., Schwartz, Ronald G., Thomas, Gregory S., Einstein, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300896/
https://www.ncbi.nlm.nih.gov/pubmed/30567577
http://dx.doi.org/10.1186/s12968-018-0510-7
_version_ 1783381764008312832
author Abidov, Aiden
Dilsizian, Vasken
Doukky, Rami
Duvall, W. Lane
Dyke, Christopher
Elliott, Michael D.
Hage, Fadi G.
Henzlova, Milena J.
Johnson, Nils P.
Schwartz, Ronald G.
Thomas, Gregory S.
Einstein, Andrew J.
author_facet Abidov, Aiden
Dilsizian, Vasken
Doukky, Rami
Duvall, W. Lane
Dyke, Christopher
Elliott, Michael D.
Hage, Fadi G.
Henzlova, Milena J.
Johnson, Nils P.
Schwartz, Ronald G.
Thomas, Gregory S.
Einstein, Andrew J.
author_sort Abidov, Aiden
collection PubMed
description Pharmacologic reversal of serious or intolerable side effects (SISE) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols.
format Online
Article
Text
id pubmed-6300896
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63008962018-12-31 Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR Abidov, Aiden Dilsizian, Vasken Doukky, Rami Duvall, W. Lane Dyke, Christopher Elliott, Michael D. Hage, Fadi G. Henzlova, Milena J. Johnson, Nils P. Schwartz, Ronald G. Thomas, Gregory S. Einstein, Andrew J. J Cardiovasc Magn Reson Review Pharmacologic reversal of serious or intolerable side effects (SISE) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols. BioMed Central 2018-12-20 /pmc/articles/PMC6300896/ /pubmed/30567577 http://dx.doi.org/10.1186/s12968-018-0510-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Abidov, Aiden
Dilsizian, Vasken
Doukky, Rami
Duvall, W. Lane
Dyke, Christopher
Elliott, Michael D.
Hage, Fadi G.
Henzlova, Milena J.
Johnson, Nils P.
Schwartz, Ronald G.
Thomas, Gregory S.
Einstein, Andrew J.
Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
title Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
title_full Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
title_fullStr Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
title_full_unstemmed Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
title_short Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR
title_sort aminophylline shortage and current recommendations for reversal of vasodilator stress: an asnc information statement endorsed by scmr
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300896/
https://www.ncbi.nlm.nih.gov/pubmed/30567577
http://dx.doi.org/10.1186/s12968-018-0510-7
work_keys_str_mv AT abidovaiden aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT dilsizianvasken aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT doukkyrami aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT duvallwlane aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT dykechristopher aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT elliottmichaeld aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT hagefadig aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT henzlovamilenaj aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT johnsonnilsp aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT schwartzronaldg aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT thomasgregorys aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr
AT einsteinandrewj aminophyllineshortageandcurrentrecommendationsforreversalofvasodilatorstressanasncinformationstatementendorsedbyscmr